NEW YORK (GenomeWeb News) – GenMark Diagnostics reported after the close of the market on Tuesday that revenues for the first quarter increased 185 percent year over year, led by reagents revenues.

For the period ended March 31, total revenues increased to $2.2 million from $758,000, as product revenues rose to $2.1 million from $693,000 while license and other revenues dropped to $39,000 from $65,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.